Polar Asset Management Partners’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,000
Closed -$5.9M 670
2025
Q2
$5.9M Sell
60,000
-65,000
-52% -$6.15M 0.09% 177
2025
Q1
$11.6M Sell
125,000
-5,000
-4% -$461K 0.27% 92
2024
Q4
$11.8M Sell
130,000
-170,000
-57% -$15.6M 0.14% 138
2024
Q3
$29M Buy
+300,000
New +$29.3M 0.61% 32
2024
Q2
Sell
-32,500
Closed -$3M 708
2024
Q1
$3M Sell
32,500
-2,500
-7% -$234K 0.05% 297
2023
Q4
$3.33M Buy
35,000
+5,000
+17% +$467K 0.06% 289
2023
Q3
$2.8M Sell
30,000
-10,000
-25% -$924K 0.06% 335
2023
Q2
$3.66M Buy
+40,000
New +$3.28M 0.07% 359
2023
Q1
Sell
-58,708
Closed -$4.9M 1051
2022
Q4
$4.9M Sell
58,708
-112,500
-66% -$10.1M 0.06% 427
2022
Q3
$16.6M Sell
171,208
-26,300
-13% -$3.14M 0.2% 129
2022
Q2
$20.8M Buy
197,508
+109,008
+123% +$13.9M 0.24% 85
2022
Q1
$15.2M Buy
88,500
+29,700
+51% +$4.44M 0.16% 147
2021
Q4
$9.52M Buy
58,800
+30,000
+104% +$4.82M 0.1% 250
2021
Q3
$4.29M Buy
+28,800
New +$5.99M 0.04% 442

Other funds holding AMED

Polar Asset Management Partners's AMED Position: Q3 2025 in Review

Polar Asset Management Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 60,000 shares — an estimated $5.9M sold.

Polar Asset Management Partners first reported a position in AMED in Q3 2021 and held it in 14 quarters. The position peaked at $29M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Polar Asset Management Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 60,000 Amedisys shares in Q3 2025, an estimated $5.9M.
  • Polar Asset Management Partners first reported a position in Amedisys in Q3 2021 and held it in 14 quarters.
  • Polar Asset Management Partners's Amedisys position peaked at $29M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.